Paediatric Consumer Health in Italy

PROSPECTS

Falling birth rates continue to limit sales development

Paediatric consumer health’s growth was curbed by the falling numbers of births in Italy in 2018. The all-time low birth rates recorded in 2016 and 2017 is leading to an increasingly older population, with fewer children, the direct consumer base of paediatric consumer health products.

Growth driven by paediatric vitamins and dietary supplements

Paediatric consumer health benefited from the positive performance of paediatric vitamins and dietary supplements in 2018. These results were linked to Italians’ increasing focus on long-term health and prevention.

Aboca’s Grintuss drives growth within paediatric cough, cold and allergy remedies

When treating their children for coughs, colds and sore throats, Italian parents are expected to increasingly favour paediatric consumer health with a herbal/traditional positioning, considered as gentler for their lack of side effects. Paediatric cough, cold and allergy remedies is set to particularly benefit from the positive performance of Aboca’s Grintuss, a herbal/traditional cough remedy which continued to gain in popularity among Italians.

COMPETITIVE LANDSCAPE

Domestic companies continue to lead

Paediatric consumer health is led by domestic players Aziende Chimiche Riunite Angelini Francesco ACRAF and Aboca. Aziende Chimiche Riunite Angelini Francesco ACRAF continued to lead due to its well-established Tachipirina brand operating in paediatric analgesics.

Aboca continues to gain share

Herbal specialist Aboca ranked second in overall paediatric consumer health and continued to gain ground in 2018. Aboca continued to benefit from Italian parents increasingly looking for gentle and natural remedies for their children, appreciating herbal/traditional remedies instead of standard OTC.

Files are delivered directly into your account within a few minutes of purchase.